NKG2A/HLA-E inhibitors (Interprotein)

N/A

Report date: 2025/03/20 15:45:52

Base Information

Drug NameNKG2A/HLA-E inhibitors (Interprotein)
Drug Alias NameNKG2A checkpoint inhibitor (Interprotein)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNK cell lectin-like receptor subfamily C member 1 antagonists
TargetsNK cell lectin-like receptor subfamily C member 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInterprotein Corp
China Registration ClassN/A

Develop Information

Active CompaniesInterprotein Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A